Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Roberts

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 17, 2001
Recurrent autoimmune hepatitis after orthotopic liver transplantationA González-Koch, A J Czaja, H A Carpenter, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 1, 1995
Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospitalL M Baddour, D V Hicks, M M Tayidi, et al.
Optics Express|December 10, 2008
Simultaneous widefield single molecule orientation and FRET microscopy in cellsS E D Webb, D J Rolfe, S R Needham, et al.
Gut|November 2, 2010
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BS J Patterson, J George, S I Strasser, et al.
Journal of Viral Hepatitis|November 21, 2017
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyA Brown, C Hézode, E Zuckerman, et al.
Journal of Viral Hepatitis|July 19, 2008
Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factorsK L Jones, L E Brown, E M Y Eriksson, et al.
Journal of Viral Hepatitis|April 18, 2017
Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort studyS Mgaieth, W Kemp, P Gow, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)G W McCaughan, P A Thwaites, S K Roberts, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3Z M Younossi, M Stepanova, I M Jacobson, et al.
Trials|July 18, 2018
Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trialA J Wade, J S Doyle, E Gane, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 17, 2001
Recurrent autoimmune hepatitis after orthotopic liver transplantationA González-Koch, A J Czaja, H A Carpenter, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 1, 1995
Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospitalL M Baddour, D V Hicks, M M Tayidi, et al.
Optics Express|December 10, 2008
Simultaneous widefield single molecule orientation and FRET microscopy in cellsS E D Webb, D J Rolfe, S R Needham, et al.
Gut|November 2, 2010
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis BS J Patterson, J George, S I Strasser, et al.
Journal of Viral Hepatitis|November 21, 2017
Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE studyA Brown, C Hézode, E Zuckerman, et al.
Journal of Viral Hepatitis|July 19, 2008
Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factorsK L Jones, L E Brown, E M Y Eriksson, et al.
Journal of Viral Hepatitis|April 18, 2017
Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort studyS Mgaieth, W Kemp, P Gow, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)G W McCaughan, P A Thwaites, S K Roberts, et al.
Alimentary Pharmacology & Therapeutics|November 29, 2017
Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3Z M Younossi, M Stepanova, I M Jacobson, et al.
Trials|July 18, 2018
Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trialA J Wade, J S Doyle, E Gane, et al.
Pageof 5